Sturm, Ruger & Company, Inc. accelerated the expiration of its shareholder rights plan (poison pill) from October 13, 2026, to September 16, 2026, effectively terminating the agreement immediately. This action follows the satisfaction of regulatory conditions under a previously announced Strategic Cooperation Agreement with Beretta Holding S.A., allowing Ruger to proceed with its strategic partnership without the defensive rights plan in place. The Board determined that an active Rights Plan is no longer necessary for shareholder interests given the current circumstances and the unchanged terms of the underlying agreement with Beretta. Sturm, Ruger & Company, Inc. operates in the firearms manufacturing industry, producing a wide range of commercial sporting firearms under brands including Ruger, Marlin, and Glenfield.
